- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 237/24 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
Patent holdings for IPC class C07C 237/24
Total number of patents in this class: 108
10-year publication summary
7
|
7
|
6
|
1
|
5
|
4
|
3
|
5
|
4
|
9
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Boehringer Ingelheim International GmbH | 4642 |
7 |
Bristol-myers Squibb Company | 4880 |
5 |
The General Hospital Corporation | 4740 |
5 |
The Broad Institute, Inc. | 1827 |
5 |
Pierre Fabre Medicament | 574 |
5 |
Massachusetts Institute of Technology | 10062 |
4 |
Oryzon Genomics S.A. | 106 |
4 |
National Center for Addiction Studies and Treatment Foundation | 4 |
4 |
Wisconsin Alumni Research Foundation | 3894 |
3 |
Dart NeuroScience, LLC | 49 |
3 |
F. Hoffmann-La Roche AG | 7947 |
2 |
Merck Patent GmbH | 5815 |
2 |
Forest Laboratories Holding Limited | 3 |
2 |
Pfizer Products Inc. | 314 |
2 |
Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. | 31 |
2 |
Sanofi-Aventis Deutschland GmbH | 2631 |
1 |
Syngenta Crop Protection AG | 6074 |
1 |
Amgen Inc. | 4076 |
1 |
Sumitomo Chemical Company, Limited | 9043 |
1 |
Toray Industries, Inc. | 6950 |
1 |
Other owners | 48 |